Home / Financial News / Jubilant Lifesciences gains on USFDA nod for generic Mycophenolate Mofetil and Rizatriptan

Jubilant Lifesciences gains on USFDA nod for generic Mycophenolate Mofetil and Rizatriptan

The company has received USFDA nod for generic Mycophenolate Mofetil and Rizatriptan

Jubilant Life Sciences

Jubilant Life Sciences

Shares of Jubilant Life Sciences has surged 7% to Rs 150 in an otherwise weak market after the company said it has received Abbreviated New Drug Application final approval from the

http://mybs.in/2RsGStS

Copy tiny URL to save and share article.

Leave a Reply

x

Check Also

Debate on Article 370 marked by posturing, says RSS

The Rashtriya Swayamsevak Sangh (RSS) is recalibrating its discourse on its demand ...

Street cautiously positive on JSPL post coal mine

Jindal Steel and Power (JSPL), which witnessed its lowest point in the ...